WS
TEVA icon

Wedbush Securities’s Teva Pharmaceuticals TEVA Stock Holding History

Wedbush Securities’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$724K Buy
21,373
+1,332
+7% +$44.4K 0.02% 589
2026
Q1 		$604K Buy
20,041
+129
+0.6% +$4.15K 0.02% 615
2025
Q4 		$621K Sell
19,912
-2,473
-11% -$60.9K 0.02% 609
2025
Q3 		$452K Buy
22,385
+390
+2% +$6.85K 0.01% 694
2025
Q2 		$369K Buy
21,995
+700
+3% +$11.3K 0.01% 741
2025
Q1 		$327K Sell
21,295
-2
-0% -$36 0.01% 767
2024
Q4 		$469K Buy
21,297
+214
+1% +$3.89K 0.02% 635
2024
Q3 		$380K Sell
21,083
-7,321
-26% -$128K 0.01% 712
2024
Q2 		$462K Sell
28,404
-3,438
-11% -$53K 0.02% 661
2024
Q1 		$449K Buy
31,842
+4,101
+15% +$51.7K 0.02% 685
2023
Q4 		$290K Sell
27,741
-775
-3% -$7.24K 0.01% 788
2023
Q3 		$291K Sell
28,516
-5,104
-15% -$47.5K 0.01% 744
2023
Q2 		$253K Sell
33,620
-1,300
-4% -$10.5K 0.01% 832
2023
Q1 		$309K Sell
34,920
-832
-2% -$8.23K 0.02% 743
2022
Q4 		$326K Sell
35,752
-5,300
-13% -$46.2K 0.02% 699
2022
Q3 		$331K Buy
41,052
+3,050
+8% +$27K 0.02% 678
2022
Q2 		$286K Sell
38,002
-250
-0.7% -$2.18K 0.02% 764
2022
Q1 		$359K Sell
38,252
-150
-0.4% -$1.25K 0.02% 727
2021
Q4 		$308K Sell
38,402
-400
-1% -$3.61K 0.01% 860
2021
Q3 		$378K Sell
38,802
-1,850
-5% -$17.3K 0.02% 743
2021
Q2 		$402K Sell
40,652
-206
-0.5% -$2.18K 0.02% 714
2021
Q1 		$471K Buy
40,858
+9,787
+31% +$112K 0.03% 599
2020
Q4 		$300K Sell
31,071
-3,657
-11% -$35K 0.03% 649
2020
Q3 		$313K Sell
34,728
-2,556
-7% -$27K 0.03% 601
2020
Q2 		$460K Sell
37,284
-14,412
-28% -$163K 0.04% 452
2020
Q1 		$464K Buy
51,696
+2,057
+4% +$21.1K 0.06% 385
2019
Q4 		$486K Buy
49,639
+7,292
+17% +$65.1K 0.04% 488
2019
Q3 		$291K Buy
42,347
+10,403
+33% +$79.7K 0.03% 651
2019
Q2 		$295K Buy
31,944
+3,559
+13% +$42.9K 0.03% 636
2019
Q1 		$445K Buy
28,385
+1,015
+4% +$17.9K 0.05% 446
2018
Q4 		$422K Sell
27,370
-3,625
-12% -$74.3K 0.05% 412
2018
Q3 		$668K Sell
30,995
-1,550
-5% -$36K 0.08% 298
2018
Q2 		$791K Sell
32,545
-15,975
-33% -$326K 0.1% 236
2018
Q1 		$829K Sell
48,520
-31,432
-39% -$614K 0.11% 224
2017
Q4 		$1.51M Sell
79,952
-17,023
-18% -$256K 0.19% 122
2017
Q3 		$1.71M Buy
96,975
+24,828
+34% +$559K 0.22% 92
2017
Q2 		$2.4M Buy
72,147
+16,980
+31% +$526K 0.31% 66
2017
Q1 		$1.77M Buy
55,167
+28,597
+108% +$976K 0.24% 83
2016
Q4 		$963K Buy
26,570
+19,020
+252% +$759K 0.14% 168
2016
Q3 		$347K Buy
7,550
+1,995
+36% +$104K 0.05% 454
2016
Q2 		$279K Buy
5,555
+322
+6% +$17.1K 0.05% 487
2016
Q1 		$280K Buy
5,233
+920
+21% +$54K 0.05% 458
2015
Q4 		$283K Sell
4,313
-193
-4% -$11.9K 0.05% 432
2015
Q3 		$254K Buy
4,506
+991
+28% +$64.3K 0.05% 442
2015
Q2 		$208K Sell
3,515
-424
-11% -$26.2K 0.04% 562
2015
Q1 		$245K Sell
3,939
-853
-18% -$49.6K 0.04% 504
2014
Q4 		$276K Sell
4,792
-1,565
-25% -$87.2K 0.04% 434
2014
Q3 		$342K Sell
6,357
-7,720
-55% -$409K 0.05% 357
2014
Q2 		$738K Sell
14,077
-16
-0.1% -$818 0.12% 182
2014
Q1 		$745K Sell
14,093
-4,053
-22% -$187K 0.13% 164
2013
Q4 		$727K Sell
18,146
-324
-2% -$12.8K 0.17% 145
2013
Q3 		$698K Sell
18,470
-62
-0.3% -$2.42K 0.18% 137
2013
Q2 		$726K Buy
+18,532
New +$722K 0.2% 132

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Wedbush Securities's TEVA Position: Q2 2026 in Review

Wedbush Securities increased its Teva Pharmaceuticals (TEVA) stake by 6.6% in Q2 2026, buying an estimated $44.4K and bringing the position to 21,373 shares worth $724K. The position accounts for 0.02% of the portfolio, ranked #589.

Wedbush Securities first reported a position in TEVA in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.4M in Q2 2017. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Wedbush Securities held 21,373 shares of Teva Pharmaceuticals worth $724K as of Q2 2026.
  • Wedbush Securities bought 1,332 Teva Pharmaceuticals shares in Q2 2026, an estimated $44.4K.
  • Teva Pharmaceuticals made up 0.02% of Wedbush Securities's portfolio in Q2 2026, its #589 holding.
  • Wedbush Securities first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
  • Wedbush Securities's Teva Pharmaceuticals position peaked at $2.4M in Q2 2017.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Wedbush Securities's 13F filing for Q2 2026, filed 28 Jul 2026.